🇺🇸 FDA

Company profile · Sponsor

TENAX

TENAX THERAPEUTICS, INC.

TENX · NYSE pharma CHAPEL HILL, NC, USA
Pipeline
7
Drugs
0
Patents
4

Quick answer

TENAX (TENX) is a pharma company. headquartered in CHAPEL HILL, NC, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 4 patents to this profile..

Company facts

Ticker TENX
Exchange NYSE
Company type pharma
Headquarters CHAPEL HILL, NC, USA
SEC CIK 0000034956

Pipeline (7)

Search pipeline →

  1. Levosimendan

    TENAX

    Coronary Artery Bypass Grafting

    phase 3 small molecule completed

    1 trial

  2. Levosimendan, The levosimendan placebo drug product is an immediate-release dosage form for oral administration.

    TENAX

    Pulmonary Hypertension (PH) with Heart Failure with preserved left ventricular ejection fraction (PH-HFpEF)

    phase 3 small molecule active

    1 trial

  3. TNX-103

    TENAX

    Pulmonary Hypertension Associated With HFpEF

    phase 3 small molecule active

    2 trials

  4. TNX-103

    TENAX

    Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  5. Levosimendan

    TENAX

    Hypertension Pulmonary Secondary Heart Failure

    phase 2 small molecule completed

    1 trial

  6. Levosimendan

    TENAX

    Hypertension Pulmonary Secondary

    phase 2 small molecule completed

    1 trial

  7. Oxycyte

    TENAX

    Traumatic Brain Injury

    phase 2 small molecule terminated

    2 trials

Patents (4)

Search patents →

  1. US 11969424

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11701355

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11607412

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11213524

    Pharmaceutical compositions for subcutaneous administration of levosimendan

    Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is TENAX?

TENAX (TENX) is a pharma company. headquartered in CHAPEL HILL, NC, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 4 patents to this profile..

What pipeline programs does TENAX sponsor?

We track 7 ClinicalTrials.gov-linked programs for TENAX, including Levosimendan and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does TENAX company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.